Navalign LLC’s Organon & Co OGN Stock Holding History

Navalign LLC’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-35	Closed	-$251	–	368
2025 Q4	$251	Buy	+35	New	+$277	﹤0.01%	481

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KBG

Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Navalign LLC's OGN Position: Q1 2026 in Review

Navalign LLC sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 35 shares — an estimated $251 sold.

Navalign LLC first reported a position in OGN in Q4 2025 and held it in 1 quarter. The position peaked at $251 in Q4 2025. 606 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

Navalign LLC reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
Navalign LLC sold 35 Organon & Co shares in Q1 2026, an estimated $251.
Navalign LLC first reported a position in Organon & Co in Q4 2025 and held it in 1 quarter.
Navalign LLC's Organon & Co position peaked at $251 in Q4 2025.
606 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Navalign LLC's 13F filing for Q1 2026, filed 29 Apr 2026.